SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS
(RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Location: Grand Ballroom East, 3rd Floor
Moderators: TBD
Moderators: TBD
10:12 AM - 10:17 AM
Although Paclitaxel Coated Devices Confer No Increase In Mortality Rates, They May Still Be Associated With Increased Amputation Rates When Used To Treat CLTI Patients: What Mechanism May Be Responsible
Presenter(s): Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor
10:18 AM - 10:23 AM
Increased Amputation Rates From Use Of Paclitaxel Coated Devices May Be Real Or A Methodological Artifact: Other Paclitaxel Coating Effects Like Embolization Or Post Atherectomy Aneurysm Formation Deserve Further Study
Presenter(s): Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
10:24 AM - 10:29 AM
Comparative Long-Term Outcomes With DESs And DCBs To Treat Fem-Pop Lesions: Unique Observations After 2-12 Years In 1000 Patients: What Is The Best Technique For Vessel Preparation
Presenter(s): Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor
10:30 AM - 10:35 AM
2-Year Results Of The SPORTS RCT – Comparing DESs (Eluvia – Boston Scientific) vs Bare Metal Stents (BMSs) vs DCBs: Which Device Is Best And In What Circumstances
Presenter(s): Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor
10:36 AM - 10:41 AM
Long-Term Results Of An RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial: How Do The Two Devices Differ
Presenter(s): Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor
10:42 AM - 10:47 AM
Long-Term Results Of The EMINENT RCT Show The Superiority Of DESs (Eluvia — Boston Scientific) Over Bare Metal Stents For Long Complex FemPop Lesions
Presenter(s): Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor
10:48 AM - 10:53 AM
DESs vs Bare Stents: Data From The TRUETA Trial: What New Information Influencing Practice Comes From This Large Data Analysis
Presenter(s): Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
10:54 AM - 10:59 AM
Directional Atherectomy As Vessel Prep For DCB Use For FemPop Lesions: For Which Lesion Characteristics Is It The Best Treatment: What Is The Evidence For Its Superiority
Presenter(s): Thomas Zeller, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM
Panel Discussion
Location: Grand Ballroom East, 3rd Floor 11:06 AM - 11:11 AM
12 Commandments For A Successful BTK Intervention In Patients With CLTI
Presenter(s): Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM
What's New And What's Next For The Treatment Of BTK Lesions: When Is POBA Still Acceptable And What About Drug Eluting And Non-Drug Eluting Devices, Resorbable Or Not
Presenter(s): Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor
11:18 AM - 11:23 AM
Updated 2-Year Results Of The DEBATE-BTK SHOCK RCT Evaluating The Value Of Lithotripsy (Shockwave-J&J) Prior To DCB Treatment In Diabetic Patients Undergoing BTK Revascularization
Presenter(s): Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:24 AM - 11:29 AM
Patency And Wound Healing Results Of The 3-French Compatible Microstent (From Micro Medical) Compare Favorably With POBA For BTK Lesions: From The STAND RCT: Antegrade And Retrograde Insertions Are Possible
Presenter(s): Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM
Update On The SELUTION4BTK RCT Comparing A Sirolimus-Coated DCB (From Cordis/Medalliance) With POBA For BTK Lesions
Presenter(s): Patrick J. Geraghty, MD / Marianne Brodmann, MD / George L. Adams, MD Location: Grand Ballroom East, 3rd Floor
11:36 AM - 11:41 AM
Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter
Presenter(s): Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:42 AM - 11:47 AM
Late (5-Year) Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency vs POBA To Treat BTK Lesions
Presenter(s): Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor
11:48 AM - 11:53 AM
Open vs Endo RevascularizationFor Patients With Infrapopliteal Disease Causing CLTI: A Large Population Based Study Confirms The Superiority Of Saphenous Vein Bypass: Newer Technologies May Alter This Conclusion
Presenter(s): Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor
11:54 AM - 12:00 PM
Panel Discussion
Location: Grand Ballroom East, 3rd Floor 12:00 PM - 1:00 PM
Lunch Break - Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
Visit Exhibits And Pavilions (2nd and 3rd Floors)